Fasting glucose tells you what your blood sugar looks like at one moment. Fasting insulin tells you how hard your pancreas is working to keep it there — and the gap between those two numbers is where insulin resistance hides for years before a glucose test ever flags it.
- Fasting glucose can look "normal" while fasting insulin signals insulin resistance years earlier
- HOMA-IR (glucose x insulin / 405) is the calculation that connects both numbers into one score
- Most standard panels skip fasting insulin entirely — you have to request it specifically
- A functional insulin target is under 10 uIU/mL, well below the standard 2-25 uIU/mL lab reference range
- Track insulin and HOMA-IR every 6-12 months, since insulin moves before glucose or HbA1c does
- GLP-1 therapy, corticosteroids, PCOS, illness, and poor sleep can all skew results temporarily
TL;DR
Fasting glucose measures the sugar circulating in your blood after 8-12 hours without food; fasting insulin measures how much of the hormone your pancreas released to manage that sugar. A patient can have a "normal" fasting glucose of 92 mg/dL in 2026 and still have fasting insulin north of 20 uIU/mL, which signals insulin resistance years before glucose numbers move. Fasting insulin vs fasting glucose isn't an either/or — pairing them through the HOMA-IR calculation is how GoodLife Health clinicians catch metabolic dysfunction while it's still reversible. Ordering both, not just glucose, is the standard GoodLife Health uses at the first weight-loss visit.
Why this matters
Most annual physicals order fasting glucose and call it done. That single number misses the early years of insulin resistance, when the pancreas is still compensating by pumping out more insulin to force the same glucose into cells.
By the time fasting glucose crosses 100 mg/dL, a patient has often been insulin resistant for five to ten years. Fasting insulin is the earlier warning — and it's the number most primary care visits skip because it isn't part of a standard metabolic panel. Checking what bloodwork to request at your first weight-loss visit before your draw means you walk in already knowing to ask for it.
Fasting insulin tells you how hard your pancreas is working to keep it there — and the gap between those two numbers is where insulin resistance hides for years before a glucose test ever flags it.
What you'll need
- A fasting window of 8-12 hours — water is fine, food and sugary drinks are not
- A lab requisition that includes both fasting glucose and fasting insulin (ask specifically; insulin is not automatic on most standard panels)
- A clinician who will calculate HOMA-IR from the two results, not just eyeball each number separately
- Your prior lab history if you have it, since trend lines matter more than one snapshot
- 15-20 minutes to review results with your provider, not a portal message with no explanation
What you eat the day before the draw skews insulin more than it skews glucose, so timing matters. Reviewing what to eat before a fasting blood draw the night before keeps a high-carb dinner from inflating your insulin result.
The steps
1. Confirm your fasting glucose range first
Fasting glucose under 100 mg/dL is standard-normal, 100-125 mg/dL is prediabetes, and 126 mg/dL or above on two separate tests is diabetes. This is the number most people already have from a routine physical.
The mistake here: treating a normal glucose reading as proof metabolic health is fine. Glucose is the last number to move, not the first.
2. Pull your fasting insulin result separately
Most labs report a reference range of roughly 2-25 uIU/mL for fasting insulin, but that range is built for detecting diabetes, not detecting early resistance. A functional target is closer to under 10 uIU/mL, and many clinicians treating metabolic health in 2026 flag anything above that for follow-up even when glucose looks fine.
The mistake here: reading "within range" on a lab report as "healthy." A result of 18 uIU/mL sits inside most reference ranges and still signals meaningful compensation.
Fasting Glucose vs Fasting Insulin
reference ranges from the article
| Marker | Reference range | What it signals |
|---|---|---|
| Fasting glucose | Under 100 mg/dL is standard-normal, 100-125 mg/dL is prediabetes, 126 mg/dL or above on two separate tests is diabetes | Confirms current blood sugar status |
| Fasting insulin | Roughly 2-25 uIU/mL reference range; a functional target is closer to under 10 uIU/mL | Confirms how hard the pancreas is working to manage blood sugar |
3. Calculate HOMA-IR
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is fasting glucose (mg/dL) multiplied by fasting insulin (uIU/mL), divided by 405. A HOMA-IR under 1.0 is considered optimal insulin sensitivity; scores above 1.9-2.0 indicate early insulin resistance, and above 2.9 is generally considered significant resistance.
The mistake here: skipping this step entirely. Two normal-looking numbers on their own can still produce a HOMA-IR above 2.5 once multiplied together.
4. Compare the two numbers against each other, not just against range
A patient with fasting glucose of 95 mg/dL and fasting insulin of 22 uIU/mL has a HOMA-IR of roughly 5.2 — solidly in resistant territory — despite a glucose reading most doctors would call fine. This is the exact pattern how doctors diagnose insulin resistance walks through in more detail, and it's the reason a glucose-only panel misses so many early cases.
The mistake here: assuming insulin and glucose move in lockstep. In early resistance, they diverge — insulin climbs while glucose holds steady, because the pancreas is compensating.
5. Track the trend over 6-12 months, not just one draw
A single fasting insulin result is a snapshot; the trend across two or three draws in the same year shows whether an intervention — GLP-1 therapy, strength training, dietary changes — is actually working. Insulin should trend down before HbA1c or weight fully reflect the change.
The mistake here: re-testing only glucose on follow-up visits because it's the number insurance covers without question. Insulin is the more sensitive marker of whether treatment is working.
A single fasting insulin result is a snapshot; the trend across two or three draws in the same year shows whether an intervention — GLP-1 therapy, strength training, dietary changes — is actually working. Insulin should trend down before HbA1c or weight fully reflect the change.
6. Factor in medications and conditions that skew results
GLP-1 medications, corticosteroids, and PCOS can all shift fasting insulin independent of underlying resistance, and an illness or poor sleep the night before a draw can spike both numbers temporarily.
The mistake here: drawing conclusions from a single result taken during an acute illness, a poor sleep stretch, or within days of starting a new medication.
Troubleshooting
Glucose is normal but insulin is elevated. This is the classic early insulin resistance pattern. It calls for HOMA-IR calculation and a conversation about diet, activity, and possibly metformin or a GLP-1, not a "come back in a year" response.
Insulin came back low despite carrying excess weight. This can reflect genuinely good insulin sensitivity, or it can reflect beta-cell exhaustion in longstanding diabetes where the pancreas has stopped compensating. Context — including HbA1c — matters here.
Results vary widely between two draws three months apart. Fasting compliance, recent illness, and sleep the night before all move insulin more than glucose. Standardize the fasting window and time of day before comparing draws.
Your lab didn't include insulin at all. Standard metabolic panels default to glucose only. You need to request fasting insulin specifically on the requisition, or work with a clinician who orders it as a default part of a weight-loss or hormone workup.
HOMA-IR came back high but you feel fine. Insulin resistance is frequently asymptomatic for years. Feeling fine is not evidence against the number — it's the reason the number matters.
Tools and resources
- A comprehensive metabolic panel plus a separate fasting insulin draw — the CMP alone won't include insulin
- HOMA-IR calculator (glucose x insulin / 405) — most clinicians run this manually or via lab software
- A clinician who reviews both numbers together, not a portal that only flags out-of-range results
- Your own tracking sheet across visits, since one lab draw in 2026 means little without a second for comparison
- How doctors use HbA1c to guide weight loss treatment for the marker that complements both glucose and insulin over a 3-month window
What to do next
Once you have both numbers and a HOMA-IR score, the next conversation is what to do about a resistant result — diet changes, strength training, metformin, or a GLP-1 protocol depending on where you land. GoodLife Health clinicians order both fasting glucose and fasting insulin as standard at the first metabolic visit, then build the treatment plan around the actual pattern in your labs rather than a single glucose number.
FAQ
Is fasting insulin or fasting glucose the better early warning sign? Fasting insulin moves first. Glucose typically stays in normal range for years while insulin climbs to compensate, so insulin catches resistance earlier than glucose alone.
What is a normal fasting insulin level? Most labs report 2-25 uIU/mL as the reference range, but a functional target for good insulin sensitivity is generally under 10 uIU/mL. Being "in range" at 20 uIU/mL still suggests meaningful compensation.
Do I need both tests, or is glucose enough? Both. Glucose alone misses the compensatory phase of insulin resistance that can last five to ten years before glucose numbers move at all.
How is HOMA-IR calculated? Multiply fasting glucose (mg/dL) by fasting insulin (uIU/mL), then divide by 405. A result under 1.0 is optimal; above 1.9-2.0 suggests early resistance.
Why didn't my doctor test fasting insulin? Insulin isn't part of a standard metabolic panel or annual physical bloodwork by default. You have to request it specifically, or see a clinician who orders it routinely for weight or hormone concerns.
Can fasting insulin be elevated even with a healthy weight? Yes. Insulin resistance tracks with visceral fat, sleep quality, and genetics, not just body weight, so normal-weight patients can still show elevated fasting insulin.
How often should fasting insulin be retested? Every 6-12 months is reasonable for monitoring a treatment response, since a single draw only shows one point in time and insulin fluctuates more than glucose day to day.
Does GLP-1 therapy lower fasting insulin? Often, yes, as weight loss and improved insulin sensitivity progress, but the number should be tracked with follow-up labs rather than assumed.
One last thing
The number most people fixate on — fasting glucose — is actually the last one to change. If you're tracking metabolic health in 2026, watch fasting insulin and HOMA-IR trend down before glucose or HbA1c fully reflect it; that lag is exactly why so many people get told their labs are "fine" for years before a diagnosis finally shows up on paper.
Related guides
- Insulin resistance and weight gain: what the labs reveal
- How doctors use HbA1c to guide weight loss treatment
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/